Atlas FDA

Exablate Model 4000 System

FDA premarket approval P150038/S019 · decided 2022-04-06

Approval details

PMA number
P150038
Supplement
S019
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Exablate Model 4000 System
Generic name
MR-guided focused ultrasound system
Applicant
Insightec
Date received
2022-03-08
Decision date
2022-04-06
Days to decision
29 days
Decision code
OK30
Product code
POH
Advisory committee
Neurology
Expedited review
No
Location
Tirat Carmel
Statement
Change is for a new Extract Trackers Data SW Tool for production in place of the usual manual extract.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.